APELLIS PHARMACEUTICALS INC

CUSIP: 03753UAB2 Class: NOTE 3.500% 9/1

LAZARD ASSET MANAGEMENT LLC's Holding History (CIK: 0001207017)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024
Shares 14,704,000 Value ($000) $16 Avg Close — Range —
Q2 2024
Shares 14,704,000 Value ($000) $19 Avg Close — Range —
Q1 2024
Shares 7,005,000 Value ($000) $11 Avg Close — Range —
Q4 2023
Shares 15,937,000 Value ($000) $26 Avg Close — Range —
Q3 2023
Shares 12,242,000 Value ($000) $15 Avg Close — Range —
Q2 2023
Shares 14,242,000 Value ($000) $34 Avg Close — Range —
Q1 2023
Shares 17,442,000 Value ($000) $33 Avg Close — Range —
Q4 2022
Shares 20,378,000 Value ($000) $31 Avg Close — Range —
Q3 2022
Shares 14,500,000 Value ($000) $28,333 Avg Close — Range —
Q2 2022
Shares 7,566,000 Value ($000) $11,331 Avg Close — Range —
Q1 2022
Shares 10,000,000 Value ($000) $15,891 Avg Close — Range —
Q4 2021
Shares 15,127,000 Value ($000) $22,945 Avg Close — Range —
Q2 2021
Shares 14,000,000 Value ($000) $25,917 Avg Close — Range —
Q4 2020
Shares 22,616,000 Value ($000) $38,169 Avg Close — Range —
Q3 2020
Shares 21,500,000 Value ($000) $23,085 Avg Close — Range —